Amanda J. Smith

Amanda J. Smith

Auto-generated profile, based on publicly available information

Amanda J. Smith

Department of Chemistry, University of Illinois at Urbana-Champaign, Illinois, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2024 in Cancer Letters
Verified
Journal Article
Open access
HGHashni Epa Vidana Gamage
Hashni Epa Vidana Gamage
SASamuel T. Albright
Samuel T. Albright
ASAmanda J. Smith
Amanda J. Smith
RFRachel Farmer
Rachel Farmer
SSSayyed Hamed Shahoei
Sayyed Hamed Shahoei
ENErik R. Nelson
Erik R. Nelson
Immune checkpoint blockade (ICB) has had limited utility in several solid tumors such as breast cancer, a major cause of cancer-related mortality in women. Therefore, there is considerable interest in alternate strategies to promote an anti-cancer immune response. A paper co-published in this issue describes how NR0B2, a protein involved in cholesterol homeostasis, functions within myeloid immune cells to modulate the inflammasome and reduce the expansion of immune-suppressive regulatory T cells (Treg). Here, we develop NR0B2 as a potential therapeutic target. NR0B2 in tumors is associated with improved survival for several cancer types including breast. Importantly, NR0B2 expression is also prognostic of ICB success. Within breast tumors, NR0B2 expression is inversely associated with FOXP3, a marker of Tregs. While a described agonist (DSHN) had some efficacy, it required high doses and long treatment times. Therefore, we designed and screened several derivatives. A methyl ester derivative (DSHN-OMe) emerged as superior in terms of (1) cellular uptake, (2) ability to regulate expected expression of genes, (3) suppression of Treg expansion using in vitro co-culture systems, and (4) efficacy against the growth of primary and metastatic tumors. This work identifies NR0B2 as a target to re-educate myeloid immune cells and a novel ligand with significant anti-tumor efficacy in preclinical models.

21 August 2024 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
ASAmanda J. Smith
Amanda J. Smith
PHPaul J. Hergenrother
Paul J. Hergenrother
Chemical inducers of apoptosis have been utilized for decades as tools to uncover steps of the apoptotic cascade and to treat various diseases, most notably cancer. While there are several useful compounds available, limitations in potency, universality, or speed of cell death of these pro-apoptotic agents have meant that no single compound is suitable for all (or most) purposes. Raptinal is a recently described small molecule that induces intrinsic pathway apoptosis rapidly and reliably, and consequently, has been utilized in cell culture and whole organisms for a wide range of biological studies. Its distinct mechanism of action complements the current arsenal of cytotoxic compounds, making it useful as a probe for the apoptosis pathway and other cellular processes. The rapid induction of cell death by Raptinal and its widespread commercial availability make it the pro-apoptotic agent of choice for many applications.

20 June 2024 in Cancer Letters
Verified
Journal Article
Open access
HGHashni Epa Vidana Gamage
Hashni Epa Vidana Gamage
SSSayyed Hamed Shahoei
Sayyed Hamed Shahoei
YWYu Wang
Yu Wang
EJElise Jacquin
Elise Jacquin
EWErin Weisser
Erin Weisser
ENErik R. Nelson
Erik R. Nelson
Although survival from breast cancer has dramatically increased, many will develop recurrent, metastatic disease. Unfortunately, survival for this stage of disease remains very low. Activating the immune system has incredible promise since it has the potential to be curative. However, immune checkpoint blockade (ICB) which works through T cells has been largely disappointing for metastatic breast cancer. One reason for this is a suppressive myeloid immune compartment that is unaffected by ICB. Cholesterol metabolism and proteins involved in cholesterol homeostasis play important regulatory roles in myeloid cells. Here, we demonstrate that NR0B2, a nuclear receptor involved in negative feedback of cholesterol metabolism, works in several myeloid cell types to impair subsequent expansion of regulatory T cells (Tregs); Tregs being a subset known to be highly immune suppressive and associated with poor therapeutic response. Within myeloid cells, NR0B2 serves to decrease many aspects of the inflammasome, ultimately resulting in decreased IL1β; IL1β driving Treg expansion. Importantly, mice lacking NR0B2 exhibit accelerated tumor growth. Thus, NR0B2 represents an important node in myeloid cells dictating ensuing Treg expansion and tumor growth, thereby representing a novel therapeutic target to re-educate these cells, having impact across different solid tumor types. Indeed, a paper co-published in this issue demonstrates the therapeutic utility of targeting NR0B2.

19 February 2024 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
YHYouming Huang
Youming Huang
XLXinghan Li
Xinghan Li
BMBinh Khanh Mai
Binh Khanh Mai
ETEmily J. Tonogai
Emily J. Tonogai
ASAmanda J. Smith
Amanda J. Smith
AHAmir H. Hoveyda
Amir H. Hoveyda

1 March 2024 in ACS Applied Bio Materials
Verified
Journal Article
Open access
ASAmanda J. Smith
Amanda J. Smith
TLTheodore R. B. Larsen
Theodore R. B. Larsen
HZHarmony K. Zimmerman
Harmony K. Zimmerman
SVSamuel J. Virolainen
Samuel J. Virolainen
JMJoshua J. Meyer
Joshua J. Meyer
DBDaniel L. Burden
Daniel L. Burden
Artificial lipid bilayers have revolutionized biochemical and biophysical research by providing a versatile interface to study aspects of cell membranes and membrane-bound processes in a controlled environment. Artificial bilayers also play a central role in numerous biosensing applications, form the foundational interface for liposomal drug delivery, and provide a vital structure for the development of synthetic cells. But unlike the envelope in many living cells, artificial bilayers can be mechanically fragile. Here, we develop prototype scaffolds for artificial bilayers made from multiple chemically linked tiers of actin filaments that can be bonded to lipid headgroups. We call the interlinked and layered assembly a multiple minimal actin cortex (multi-MAC). Construction of multi-MACs has the potential to significantly increase the bilayer's resistance to applied stress while retaining many desirable physical and chemical properties that are characteristic of lipid bilayers. Furthermore, the linking chemistry of multi-MACs is generalizable and can be applied almost anywhere lipid bilayers are important. This work describes a filament-by-filament approach to multi-MAC assembly that produces distinct 2D and 3D architectures. The nature of the structure depends on a combination of the underlying chemical conditions. Using fluorescence imaging techniques in model planar bilayers, we explore how multi-MACs vary with electrostatic charge, assembly time, ionic strength, and type of chemical linker. We also assess how the presence of a multi-MAC alters the underlying lateral diffusion of lipids and investigate the ability of multi-MACs to withstand exposure to shear stress.

28 October 2026 in ACS Chemical Biology
Verified
Journal Article
Closed access
LBLindsay E. Boudreau
Lindsay E. Boudreau
ASAmanda J. Smith
Amanda J. Smith
HLHyang Yeon Lee
Hyang Yeon Lee
BCBidisha Chakraborty
Bidisha Chakraborty
KAKyle R. Abo
Kyle R. Abo
PHPaul J. Hergenrother
Paul J. Hergenrother